Evidence map›Paper›PMID 41809481›Full record

ArticleWorld journal of hepatology2026

Should the routine use of the 6-minute walk test be implemented in liver disease assessment: Not so fast.

Marco E Diaz-Cordova, Ishani Sharma, William Pascal, Kenji Okumura

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in World journal of hepatology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Marco E Diaz-CordovaDepartment of Surgery, Westchester Medical Center and New York Medical College, Valhalla, NY 10595, United States.
Ishani SharmaDepartment of Surgery, Westchester Medical Center and New York Medical College, Valhalla, NY 10595, United States.
William PascalDepartment of Surgery, Westchester Medical Center and New York Medical College, Valhalla, NY 10595, United States.
Kenji OkumuraDepartment of Surgery, Westchester Medical Center and New York Medical College, Valhalla, NY 10595, United States. kenjiokumura@kyudai.jp.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

End-stage liver disease (ESLD) is a debilitating condition that often leads to death. Once diagnosed with ESLD, a patient's quality of life decreases significantly. Well-established markers, such as the model for end-stage liver disease and Child-Pugh scores, are used to diagnose, monitor, and predict survival. Another tool, the 6-minute walk test (6MWT), has shown promise as an adjunct measure but remains underutilized despite its strong results and ease of reproducibility. Previous research has demonstrated that the 6MWT, as in many other conditions, helps predict survival, mortality, and outcomes in individuals with ESLD. A recent observational study by Corrêa

Indexed as

6-minute walk testCirrhosisFunctional capacityLiver failureLiver transplant

Identifiers

PMID41809481
PMCPMC12968681

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.